MALAT1 and diabetic retinopathy: MALAT1 activates Keap1′s transcription, thus impeding Nrf2 nuclear movement and inhibiting the transcription of the antioxidant response enzymes in HRECs, in vivo and in retinal microvessels from human donors with diabetic retinopathy [34].